about
Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivoExtracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineCorrelative Imaging of the Murine Hind Limb Vasculature and Muscle Tissue by MicroCT and Light Microscopy.Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent.Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels.Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purificationTherapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB.Critical role of microenvironmental factors in angiogenesis.VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1+ monocyte/TGF-β1 paracrine axisThe effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarctionLong-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscle.Cell and gene therapy approaches for cardiac vascularization.Non-adherent mesenchymal progenitors from adipose tissue stromal vascular fraction.Adipose tissue-derived progenitors for engineering osteogenic and vasculogenic grafts.Split for the cure: VEGF, PDGF-BB and intussusception in therapeutic angiogenesis.Macrophage-mediated angiogenic activation of outgrowth endothelial cells in co-culture with primary osteoblasts.Engineered mesenchymal cell-based patches as controlled VEGF delivery systems to induce extrinsic angiogenesis.VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting.Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c.Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo.Scaffold Composition Determines the Angiogenic Outcome of Cell-Based Vascular Endothelial Growth Factor Expression by Modulating Its Microenvironmental Distribution.VEGF, shear stress and muscle angiogenesis: a complicated triangle.Rapid and efficient magnetization of mesenchymal stem cells by dendrimer-functionalized magnetic nanoparticles.Osteogenic graft vascularization and bone resorption by VEGF-expressing human mesenchymal progenitors.Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle.Spontaneous In Vivo Chondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling.Localization of vascular response to VEGF is not dependent on heparin binding.B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart.Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy.Myoblast-mediated gene transfer for therapeutic angiogenesis.It Takes Two to Tango: Coupling of Angiogenesis and Osteogenesis for Bone Regeneration.Vascular Endothelial Growth Factor Sequestration Enhances In Vivo Cartilage Formation.Three dimensional multi-cellular muscle-like tissue engineering in perfusion-based bioreactors.Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells.Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia.EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels.
P50
Q24298258-B6D4AF6F-F5E7-4DBF-98B8-BE562712D0BFQ26829783-EABE94BE-60AC-4716-9B7C-016D18A390F1Q30837730-A6852BDB-A455-460E-BA98-85C55CCAD41EQ33586324-21B9D1CC-14DF-4C79-AE73-E810FF7E917FQ33586957-37463CD0-A67B-4C4F-9901-501B18136E77Q33627325-561E21C0-423B-4889-8B5E-A45D6ACFECB5Q35554334-BF811964-BE92-4877-8FEC-E0A2A11A53D2Q35851399-AC444DBD-D137-44B3-A86E-67D97E822C59Q35987897-F0316EBD-C4B8-4F2C-9C0C-29AE47B1E79CQ36089540-6B38109A-7A83-44AD-B488-4CD437A90F07Q36159478-E25065B4-16E4-47BC-B5E7-A84D5AE15825Q36374351-3213DBC4-64D5-4425-81C4-3FA854E303CEQ36587779-1C940A53-C8D5-4E33-8CF9-99D6E0EAB535Q37512327-579E326B-D17B-4DFB-9E5A-D12EF10B8399Q37610680-CE728EF9-D13B-4766-BDDD-D5174B78ECE9Q37772148-73AE5EB7-043A-4236-BFF8-18737D138769Q38268460-8AFD5395-D751-4E97-A308-FFBDE633CB64Q39022367-85A13966-F593-4F64-AAB1-70DBB5F94ED6Q39549017-D6C689E5-745F-48C9-B484-C1160A7099F0Q44037274-E24AB497-CA68-4121-A5F1-F3B4D06FAC42Q44998864-3C715B52-435A-4CCE-96BD-1247713E5F89Q45374311-1E16A70E-6EB8-4307-88B4-EDE944A608DEQ45855976-51185D41-5E66-4A75-B7AB-7EF78F0DA40AQ45872982-9F434AD4-7223-46D7-B1A9-F8ABB46C845FQ45875314-F1C7FF79-8761-4F14-8310-8519B8C9B54BQ45886040-C7B7386D-DECF-4D5D-BC31-353B28197412Q45886488-225CDC2D-EE24-46C4-AEBE-B238E88E5ECAQ45981429-B3C174B3-80B1-4EB4-957A-BDB6F46B1F54Q46092429-AD8FBD3D-15F2-4AF7-9CFD-0388F95B811FQ46147238-24B3DE7D-F61F-480F-B4D5-E3A109AEED6DQ46530175-9203BA49-63E0-4A39-960D-2E4DB1A137D5Q46549703-6B6042C7-F3CB-4F5E-94ED-E150B5D6263BQ46733913-A74E5288-ABD7-4E38-8E17-83A266867777Q46894342-237AC79C-98E4-4AA0-A8E6-6E409A1FC07EQ47153246-4908677E-F314-4366-8AD2-AE79AC602C08Q50853149-9E2A1472-96E9-4C99-9048-C8F0A0E62C54Q51031745-5B5E1534-B597-4ECF-BE02-61812F72215EQ52002244-4EFE050F-9BB2-4566-B6BB-602D8F37F8FDQ55004289-941592CA-B340-40DD-A080-BC669C6D7029Q55395190-C9AE6063-60F1-46C0-971A-45FAA5F49991
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea Banfi
@ast
Andrea Banfi
@en
Andrea Banfi
@es
Andrea Banfi
@nl
type
label
Andrea Banfi
@ast
Andrea Banfi
@en
Andrea Banfi
@es
Andrea Banfi
@nl
prefLabel
Andrea Banfi
@ast
Andrea Banfi
@en
Andrea Banfi
@es
Andrea Banfi
@nl
P1053
B-8720-2008
P106
P1153
36238878400
P2798
P31
P3829
P496
0000-0001-5737-8811